BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.99% | 116.08% | -66.15% | -11.42% | 85.04% |
| Total Depreciation and Amortization | -14.19% | 11.09% | 6.00% | 4.11% | -16.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.52% | -125.82% | 854.63% | 228.82% | -119.43% |
| Change in Net Operating Assets | -256.83% | 894.70% | 20.23% | 93.75% | -437.25% |
| Cash from Operations | -64.62% | -1.43% | -13.80% | 123.04% | -56.38% |
| Capital Expenditure | -1,374.00% | 101.86% | -28.87% | 75.25% | 35.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.97% | -17,800.00% | 71.43% | -600.00% | 97.83% |
| Cash from Investing | -179.49% | 91.31% | -28.53% | 75.17% | 35.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 29.07% | -15.99% | 6.65% | -2.76% | 29.26% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -11,375.27% | -- | -- | -- |
| Cash from Financing | 28.22% | -117.23% | 102.09% | -29,691.57% | 69.39% |
| Foreign Exchange rate Adjustments | -179.73% | 311.19% | -233.38% | -121.69% | 175.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.59% | -1.19% | 118.80% | -1,302.20% | -47.33% |